QTc interval prolongation predicts postoperative mortality: In heart failure patients undergoing surgical revascularization

Texas Heart Institute Journal

Volumn 33, Issue 1, 2006, Pages 3-8

  Vrtovec, Bojan ^a   Yazdanbakhsh, Aria P ^a   Pintar, Tatjana ^a   Collard, Charles D ^a   Gregoric, Igor D ^a   Radovancevic, Branislav ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

Author keywords

Coronary disease surgery; Electrocardiography; Heart failure; Long QT syndrome; Mortality; Myocardial revascularization; Prognosis; Risk factors; Treatment outcome

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QT PROLONGATION; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33645554648     PISSN: 07302347     EISSN: 07302347     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402.
2. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
3. Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 2000;321:540-5.
4. Ascione R, Narayan P, Rogers CA, Lim KH, Capoun R, Angelini GD. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg 2003;76:793-9.
5. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg 1998;66:1632-9.
6. Gardner SC, Grunwald GK, Rumsfeld JS, Mackenzie T, Gao D, Perlin JB, et al. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 2001;72:2033-7.
7. Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003;107:1764-9.
8. Elming H, Brendorp B, Kober L, Sahebzadah N, Torp-Petersen C. QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev 2002;6:289-94.
9. Toivonen L. More light on QT interval measurement. Heart 2002;87:193-4.
10. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
11. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999;100:1464-80.
12. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-61.
13. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998;98:1928-36.
14. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 2002;17:43-51.
15. Boccalandro F, Velasco A, Thomas C, Richards B, Radovancevic B. Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92:544-7.
16. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001;21:661-72.
17. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 2002;39:1820-6.
18. Brendorp B, Elming H, Jun L, Kober L, Malik M, Jensen GB, et al. Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 2001;103:1422-7.
19. Hannan EL, Racz MJ, Walford G, Ryan TJ, Isom OW, Bennett E, Jones RH. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA 2003;290:773-80.
20. De Carlo M, Milano A, Borzoni G, Pratali S, Barzaghi C, Tartarini G, et al. Predicting outcome after myocardial revascularization in patients with left ventricular dysfunction. Cardiovasc Surg 1998;6:58-66.
21. Wranicz JK, Ruta J, Strzondala M, Kosmider M, Bolinska H, Zaslonka J. QT interval duration in 24-hour Holter monitoring after different interventional treatment of coronary artery disease in patients after the myocardial infarction. Med Sci Monit 2000;6:100-2.
22. Harding JD, Piacentino V 3rd, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001;104:1241-7.
23. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749-66.